Tempo Therapeutics Wins $2.25M NIH SBIR Grant for MAP Wound Healing
Tempo Therapeutics secured a $2.25 million NIH SBIR grant to advance its MAP™ platform for complex wound healing, adding federal backing to tissue-engineered wound repair.
Topic
Topic
Tempo Therapeutics secured a $2.25 million NIH SBIR grant to advance its MAP™ platform for complex wound healing, adding federal backing to tissue-engineered wound repair.